{
  "url": "https://openlegislation.uk/eu-regulation-2020-692/annex-XIII/division-1",
  "json_url": "https://openlegislation.uk/eu-regulation-2020-692/annex-XIII/division-1.json",
  "legislation": "eur/2020/692",
  "legislation_title": "Commission Delegated Regulation (EU) 2020/692 of 30 January 2020 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for entry into the Union, and the movement and handling after entry of consignments of certain animals, germinal products and products of animal origin (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2020-692",
  "path": "annex/XIII/division/1",
  "kind": "division",
  "number": "1",
  "heading": "MINIMUM REQUIREMENTS FOR VACCINATION PROGRAMMES CARRIED OUT IN A THIRD COUNTRY OR TERRITORY OR ZONE THEREOF",
  "text": "Vaccination programmes against highly pathogenic avian influenza submitted by a third country or territory must include at least the following information:\n(1) objectives of the vaccination strategy, selected bird population(s) and area;\n(2) data on the epidemiological evolution of the disease, including previous outbreaks in poultry or wild birds;\n(3) description of the reasons for the decision to introduce the vaccination;\n(4) risk assessment based on:\nhighly pathogenic avian influenza outbreaks within that third country or territory or zone thereof,\nhighly pathogenic avian influenza outbreak in a neighbouring country,\nother risk factors such as certain areas, type of poultry husbandry or categories of poultry or captive birds;\n(5) geographical area where vaccination is carried out;\n(6) number of establishments in vaccination area;\n(7) number of establishments where vaccination is carried out, if different from the number in point 6;\n(8) species and categories of poultry or captive birds in the geographical area where vaccination is carried out;\n(9) approximate number of poultry or captive birds in the establishments referred to in point 7;\n(10) summary of the vaccine characteristics, authorisation and quality control;\n(11) handling, storage, supply, distribution and sale of avian influenza vaccines on the national territory;\n(12) implementation of a Differentiating Infected from Vaccinated Animals (DIVA) strategy;\n(13) envisaged duration of vaccination campaign;\n(14) provisions and restrictions on movements of vaccinated poultry and poultry products derived from vaccinated poultry or vaccinated captive birds;\n(15) clinical and laboratory tests, such as efficacy and pre-movement testing, carried out in the establishments vaccinated or located in the vaccination area;\n(16) means of record keeping.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2020/692/annex/XIII/division/1",
    "retrieved_at": "2026-11-01T14:42:36.901874+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}